EAU 2013 - Programme Book - YouMed

Sunday, 17 March - EAU Programme
Abstract Session
09.15 - 10.45 Bladder cancer: Pathology
Brown Hall 3 - Level S2
Poster Session 24
Chairs: P-U. Malmström, Uppsala (SE)
Y.M. Osman, Mansoura (EG)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion. Extended presentations (*) are 4 minutes in length, followed
by 2 minutes for discussion.
276 Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the
bladder treated with radical cystectomy
E.N. Xylinas, M. Rink, L. Kluth, B.D. Robinson, Y. Lotan, M. Babjuk, A. Brisuda, D.A. Green, A. Pycha,
Y. Fradet, R.K. Lee, P.I. Karakiewicz, M. Zerbib, D.S. Scherr, S.F. Shariat (New York, Dallas, United States of
America; Prague, Czech Republic; Bolzano, Italy; Quebec City, Montreal, Canada; Paris, France)
277 Methylation of tumor suppressor genes predict recurrence and subclassify non muscle-invasive disease:
PTA low grade versus pt1 low grade and pt1 high grade bladder tumors
R. Sacristan, C. Gonzalez, J.M. Fernandez-Gomez, F. Fresno, S. Escaf, M. Sanchez-Carbayo (Madrid, Spain)
278 Could a mutational status of fibroblast growth factor receptor 3 (FGFR3) gene in bladder cancer tissue
improve accuracy of clinical staging?
A.I. Rolevich, M.P. Smal, S.A. Krasny, R.I. Goncharova, S.L. Polyakov, T.I. Nabebina (Minsk, Belarus)
279 Practical potential of immunohistochemical staining with anti-smoothelin, anti-vimentin and anticaldesmon
antibodies in pathological staging of urothelial bladder carcinoma
S. Poletajew, E. Wilczek, D. Łukasik, A. Wasiutynski, B. Górnicka (Warsaw, Poland)
280 Micropapillary variant of urothelial carcinoma in the upper urinary tract
H.H. Sung, J.J. Kim, K.S. Lee, S.H. Choo, H.J. Jang, Y.S. Suh, S. Jeong, W. Song, J. Cho, G.Y. Kwon, H.G. Jeon,
B.C. Jeong, S.I. Seo, S.S. Jeon, H-Y. Choi, H.M. Lee (Seoul, South Korea)
281 Multivariate analysis of clinical and pathological predictive factors of understaging, in patients undergoing
radical cystectomy
A. De Gracia, O. Rodriguez Faba, J. Palou, F. Algaba, J.M. Gaya, A. Breda, L.I. Gausa, A. Wong,
H. Villavicencio (Barcelona, Spain)
282 Outcome of radical cystectomy for muscle-invasive bladder cancer secondary to previous non muscleinvasive
stages is comparable to primary muscle-invasive bladder cancer and impacted by EORTC riskscore
A. Aziz, M. Gierth, H-M. Fritsche, M. May, W. Otto, W. Wieland, S. Denzinger, A. Merseburger, H. Riedmiller,
A. Kocot, M. Burger (Regensburg, Straubing, Hanover, Würzburg, Germany)
EAU Milan 2013
149
Sunday